TISSUE & FFPE COHORT COLLECTIONS
Colorectal cancer tissue microarrays & FFPE blocks
Explore colorectal cancer arrays with different tissue compositions and selected MSI, molecular, treatment or matched-plasma records. For FFPE blocks, share your tissue and study requirements with our team.
THE ARRAYS
Colorectal cancer arrays (62)
Collection types in this TMA catalog
Explore the tissue composition and sampling groups represented in these arrays.
Colon adenoma (TA1967)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
CRC (BRAF mutated & WT) with histopath data (TA4332)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC (I-III) with KRAS mutation status & histopath data (TA1246)
- Approx. cores
- 132
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC non-responders to any SOC first line therapy, pretreatment samples with follow up data (TA1849)
- Approx. cores
- 132
- Approx. donors
- 66
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
CRC primary & matched liver mets with histopath data (TA1346)
- Approx. cores
- 116
- Approx. donors
- 58
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC primary & matched liver mets with histopath data (TA4494)
- Approx. cores
- 80
- Approx. donors
- 75
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
CRC primary & matched liver mets, normal colon & MSI status with histopath data (Same as TA4427) (TA4455)
- Approx. cores
- 72
- Approx. donors
- 30
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC primary & matched liver mets, normal colon & MSI status with histopath data (TA4427)
- Approx. cores
- 71
- Approx. donors
- 30
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC primary & matched nodal mets (TA4491)
- Approx. cores
- 89
- Approx. donors
- 49
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC primary with Bevacizumab treatment & follow up data (metastatic & adjuvant setting), KRAS mutation status (TA1324)
- Approx. cores
- 170
- Approx. donors
- 85
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
CRC primary,mets with follow up (Beva, Cetuximab etc.) & MSI data (TMA4111_02)
- Approx. cores
- 136
- Approx. donors
- 109
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
CRC SOC matched (TA1856)
- Approx. cores
- 34
- Approx. donors
- 23
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
CRC TMA block 1 of 9, 2×1.5mm cores per donor, 1.2×1.2cm window for core placement, ~24×1.5mm cores (12 donors) per TMA block. (TA4470)
- Approx. cores
- 24
- Approx. donors
- 12
- Core diameter
- 1.5 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA block 2 of 9 (primary & mets) (TA4471)
- Approx. cores
- 24
- Approx. donors
- 12
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (Same as TA4400) (TA4449)
- Approx. cores
- 120
- Approx. donors
- 40
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (Same as TA4401) (TA4450)
- Approx. cores
- 120
- Approx. donors
- 40
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (Same as TA4403) (TA4452)
- Approx. cores
- 119
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (Same as TA4407) (TA4453)
- Approx. cores
- 123
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (TA4400)
- Approx. cores
- 120
- Approx. donors
- 40
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (TA4401)
- Approx. cores
- 120
- Approx. donors
- 40
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (TA4402)
- Approx. cores
- 120
- Approx. donors
- 40
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (TA4403)
- Approx. cores
- 119
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (TA4407)
- Approx. cores
- 123
- Approx. donors
- 44
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA Block with histopath data & Her2 IHC scores (4B5) (TA4451)
- Approx. cores
- 120
- Approx. donors
- 40
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC TMA with approximately 70 donors MSI-H & 50 donors MSS, histopath data (TA4417)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with Cetuximab data (TA1373)
- Approx. cores
- 110
- Approx. donors
- 55
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with follow up (Beva, Cetuximab etc.) & MSI data (TMA4111_01)
- Approx. cores
- 176
- Approx. donors
- 176
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3130)
- Approx. cores
- 140
- Approx. donors
- 140
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3132)
- Approx. cores
- 140
- Approx. donors
- 140
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3135)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3136)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3137)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3138)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3145)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3146)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3147)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA3148)
- Approx. cores
- 100
- Approx. donors
- 100
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA4352)
- Approx. cores
- 144
- Approx. donors
- 117
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA4353)
- Approx. cores
- 144
- Approx. donors
- 73
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath & HER2 IHC data (TA4355)
- Approx. cores
- 144
- Approx. donors
- 48
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath data (TA4374)
- Approx. cores
- 129
- Approx. donors
- 42
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
CRC with histopath data (TA4375)
- Approx. cores
- 129
- Approx. donors
- 43
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
CRC with histopath data (TA4376)
- Approx. cores
- 129
- Approx. donors
- 43
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
CRC with histopath data, MSI-H with RNAscope PPIB scores (TA4342)
- Approx. cores
- 29
- Approx. donors
- 29
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with histopath, MSI-H & HER2 IHC data (TA4354)
- Approx. cores
- 141
- Approx. donors
- 47
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
CRC with MSI & HER2 IHC, KRAS mutation status and histopath data (TA3122)
- Approx. cores
- 140
- Approx. donors
- 140
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
IO Multi tumor array 4 of a set of 6 TMAs: CRC, Gastric ADC, Pancreatic ADC, Cholangiocarcinoma, GEJ with histopath data. 1x1mm core each from tumor & invasive edge (TA3127)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
IO Multi tumor array 4 of a set of 6 TMAs: CRC, Gastric ADC, Pancreatic ADC, Cholangiocarcinoma, GEJ with histopath data. 1x1mm core each from tumor & invasive edge (TA4441)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
MSI status CRC TMA (TA4469)
- Approx. cores
- 60
- Approx. donors
- 57
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
MSS CRC: 50 pre- and 50 post- SOC samples/cores, 10 sets (20 blocks) matched pre & post treatment. CRC TMA block 1 of 2 (FFPE) (TA4481)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
MSS CRC: 60 pre- and 60 post- SOC samples/cores, mix of matched and unmatched donor samples for pre/post.CRC TMA block 2 of 2 (FFPE) (TA4482)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Multi tumor array 1 of a set of 4 TMAs : Breast cancer ER+, Her2+, TNBC, CRC, NSCLC, Prostate ADC with histopath data (TA2995)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Marker / molecular data listed
Multi tumor array comprising breast, bladder(uc), ovarian, lung, prostate, melanoma, RCC , head & neck SCC, CRC, pancreatic ADC with histopath data (TA4340)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array comprising cores with high immune infiltrates from Pancreatic, Melanoma, Breast, HCC & CRC. TMA2 of a set of 2 TMAs, histopath data (TA4313)
- Approx. cores
- 120
- Approx. donors
- 60
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4321)
- Approx. cores
- 124
- Approx. donors
- 64
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4331)
- Approx. cores
- 110
- Approx. donors
- 69
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Multi tumor array with histopath data & matched plasma with PPIB scores (TA4341)
- Approx. cores
- 45
- Approx. donors
- 24
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
Normal (non-malignant) breast, colon, lymph node, lung, prostate & breast cancer, CRC, prostate ADC, NSCLC & DLBCL, 2mm (TA2942)
- Approx. cores
- 30
- Approx. donors
- 30
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
NSCLC & CRC with IO treatment follow up data & PPIB scores (TA4498)
- Approx. cores
- 44
- Approx. donors
- 43
- Core diameter
- 1 mm
- Clinical follow-up
- Follow-up listed
- Marker & molecular data
- Marker / molecular data listed
RNAscope pre-qualified multi tumor array 120 cores total, 1mm core diameter – (same as previous TA4380) (TA4388)
- Approx. cores
- 120
- Approx. donors
- 120
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
RNAscope pre-qualified multi tumor array, 2mm core diameter, TMA2 of a set of 2 TMAs, histopath data (TA3118)
- Approx. cores
- 60
- Approx. donors
- 60
- Core diameter
- 2 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
tumor & invasive edge cores/donor, CRC, PDAC, Gastric ADC, HCC, GEJ (TA3105)
- Approx. cores
- 144
- Approx. donors
- 72
- Core diameter
- 1 mm
- Clinical follow-up
- Not listed
- Marker & molecular data
- Not listed
No arrays match these filters
Try another search or clear the filters to see this collection.
Data labels reflect the catalog record. Review each product and datasheet for case-level coverage. Array counts do not indicate stock availability.
FFPE TISSUE BLOCKS
Colorectal cancer FFPE blocks for your study
Colorectal cancer cohorts with mutation, HER2, MSI, treatment, metastasis or matched-plasma data, plus colon adenoma.
FFPE blocks are requested by inquiry. Our team confirms tissue availability, donor matching and data coverage for your study.
FFPE TISSUE COHORTS
Colorectal cancer FFPE cohorts
Select a cohort or patient profile, then share your sample and data requirements with our team.
Cohort #42
CRC (BRAF mutated & WT) with histopath data
Cohort #43
CRC (I-III) with KRAS mutation status & histopath data
Cohort #45
CRC with histopath data & Her2 IHC scores (4B5)
Cohort #47
CRC non-responders to any SOC first line therapy, pretreatment samples with follow up data
Cohort #48
CRC primary & matched liver mets with histopath data
Cohort #52
CRC primary, mets with follow up (Beva, Cetuximab etc.) & MSI data
Cohort #53
CRC with Cetuximab data
Cohort #54
CRC with MSI & HER2 IHC, KRAS mutation status and histopath data
Cohort #56
CRC with follow up (Beva, Cetuximab etc.) & MSI data
Cohort #59
CRC with histopath data, MSI-H
Cohort #179
CRC with matched double spun plasma
Cohort #61
Colon adenoma
Colorectal cancer · Patient profile
Metastatic disease with MSS, MSI-H, KRAS, NRAS or BRAF profiles
Colorectal cancer · Patient profile
Microsatellite-stable (MSS) colorectal cancer
Colorectal cancer · Patient profile
dMMR / MSI-H colon cancer
Colorectal cancer · Patient profile
dMMR / MSI-H rectal cancer
Colorectal cancer · Patient profile
Left-sided KRAS/NRAS/BRAF wild-type disease
Colorectal cancer · Patient profile
Second-line KRAS/NRAS/BRAF wild-type disease with prior chemotherapy
SELECTING YOUR ARRAY
Selecting colorectal cancer tissue for your study
Compare the represented tissue and the available records before choosing an array. These examples describe individual catalog entries; data coverage is specific to each array.
TA1246 tissue composition
CRC (I-III) with KRAS mutation status & histopath data (TA1246).
TA1324 tissue composition
CRC primary with Bevacizumab treatment & follow up data (metastatic & adjuvant setting), KRAS mutation status (TA1324).
TA1346 tissue composition
CRC primary & matched liver mets with histopath data (TA1346).





























